A	O
NOTCH1	O
-	O
driven	O
MYC	O
enhancer	O
promotes	O
T	O
cell	O
development	O
,	O
transformation	O
and	O
acute	B-DISEASE
lymphoblastic	I-DISEASE
leukemia	E-DISEASE
.	O


Efforts	O
to	O
identify	O
and	O
annotate	O
cancer	S-DISEASE
driver	O
genetic	O
lesions	O
have	O
been	O
focused	O
primarily	O
on	O
the	O
analysis	O
of	O
protein	O
-	O
coding	O
genes	O
;	O
however	O
,	O
most	O
genetic	O
abnormalities	O
found	O
in	O
human	O
cancer	S-DISEASE
are	O
located	O
in	O
intergenic	O
regions	O
.	O


Here	O
we	O
identify	O
a	O
new	O
long	O
range	O
-	O
acting	O
MYC	O
enhancer	O
controlled	O
by	O
NOTCH1	O
that	O
is	O
targeted	O
by	O
recurrent	O
chromosomal	O
duplications	O
in	O
human	O
T	B-DISEASE
cell	I-DISEASE
acute	I-DISEASE
lymphoblastic	I-DISEASE
leukemia	E-DISEASE
(	O
T	B-DISEASE
-	I-DISEASE
ALL	E-DISEASE
)	O
.	O


This	O
highly	O
conserved	O
regulatory	O
element	O
,	O
hereby	O
named	O
N	O
-	O
Me	O
for	O
NOTCH	O
MYC	O
enhancer	O
,	O
is	O
located	O
within	O
a	O
broad	O
super	O
-	O
enhancer	O
region	O
+	O
1	O
.	O
47	O
Mb	O
from	O
the	O
MYC	O
transcription	O
initiating	O
site	O
,	O
interacts	O
with	O
the	O
MYC	O
proximal	O
promoter	O
and	O
induces	O
orientation	O
-	O
independent	O
MYC	O
expression	O
in	O
reporter	O
assays	O
.	O


Moreover	O
,	O
analysis	O
of	O
N	O
-	O
Me	O
knockout	O
mice	O
demonstrates	O
a	O
selective	O
and	O
essential	O
role	O
of	O
this	O
regulatory	O
element	O
during	O
thymocyte	O
development	O
and	O
in	O
NOTCH1	O
-	O
induced	O
T	B-DISEASE
-	I-DISEASE
ALL	E-DISEASE
.	O


Together	O
these	O
results	O
identify	O
N	O
-	O
Me	O
as	O
a	O
long	O
-	O
range	O
oncogenic	O
enhancer	O
implicated	O
directly	O
in	O
the	O
pathogenesis	O
of	O
human	O
leukemia	S-DISEASE
and	O
highlight	O
the	O
importance	O
of	O
the	O
NOTCH1	O
-	O
MYC	O
regulatory	O
axis	O
in	O
T	O
cell	O
transformation	O
and	O
as	O
a	O
therapeutic	O
target	O
in	O
T	B-DISEASE
-	I-DISEASE
ALL	E-DISEASE
.	O
